News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK)'s Shingles Vaccine Not Reaching Enough U.S. Adults



9/12/2013 7:30:17 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Too few American adults have been vaccinated for shingles, the painful sibling to chicken pox, according to research that calls for efforts to increase the U.S.-recommended inoculation. Fewer than 2 of 10 Americans ages 60 and older have been vaccinated, while the rate is less than half that for those in their 50s, according to a study presented today at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver. Almost one-third of Americans will get shingles in their lifetime, with about 1 million cases in the U.S. each year, the Centers for Disease Control and Prevention said.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   
Shingles
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES